Log in to save to my catalogue

Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas

Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03837365v1

Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas

About this item

Full title

Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas

Publisher

US: Oxford University Press

Journal title

The journal of clinical endocrinology and metabolism, 2022-10, Vol.107 (10), p.2801-2810

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Context
Pheochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that are frequently associated with succinate dehydrogenase (SDH) germline mutations. When mutated, SDH losses its function, thus leading to succinate accumulation.
Objective
In this study, we evaluated serum succinate levels as a new metabolic b...

Alternative Titles

Full title

Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03837365v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03837365v1

Other Identifiers

ISSN

0021-972X

E-ISSN

1945-7197

DOI

10.1210/clinem/dgac474

How to access this item